Keyphrases
Signaling Pathway
100%
Cyclooxygenase-2
100%
Notch1
100%
Notch Receptors
100%
Gastric Cancer Progression
100%
Intracellular Domain
80%
M1 Cells
80%
Gastric Cancer
60%
Jagged1
60%
Knockdown
40%
Promoter Binding
40%
Aggressiveness
40%
Invasion Ability
40%
Migration Ability
40%
Colony-forming Ability
40%
Binding Factors
40%
Molecular Mechanism
20%
Malignancy
20%
Tumor Growth
20%
Regulatory Mechanism
20%
Poor Survival
20%
Survival Rate
20%
Prostaglandin E2
20%
Cyclooxygenase-2 Inhibitors
20%
Gastric Tissue
20%
Common Cancers
20%
Cellular Processes
20%
Gastric Carcinoma
20%
Cyclooxygenase-2 Expression
20%
New Therapeutic Strategies
20%
Xenografted Tumor
20%
Stomach Adenocarcinoma
20%
Human Stomach
20%
Human Gastric Cancer
20%
Notch Ligands
20%
NS-398
20%
Medicine and Dentistry
Cancer Growth
100%
Cyclooxygenase 2
100%
Cell Signaling Pathway
100%
Abdominal Cancer
100%
Notch1 Receptor
83%
Intracellular Receptor
66%
Promoter Region
50%
Protein Jagged 1
50%
Fibrinogen
33%
Malignant Neoplasm
16%
Tumor Progression
16%
Cancer
16%
Cancer Tissue
16%
Survival Rate
16%
Colony Forming Unit S
16%
Prostaglandin E2
16%
Stomach Adenocarcinoma
16%
Stomach Carcinoma
16%
Notch
16%
Cyclooxygenase 2 Inhibitor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Cancer Growth
100%
Cyclooxygenase 2
100%
Abdominal Cancer
100%
Notch1 Receptor
83%
Protein Jagged 1
50%
Fibrinogen
33%
Malignant Neoplasm
16%
Tumor Growth
16%
Prostaglandin E2
16%
COX-2 Inhibitor
16%
Survival Rate
16%
Stomach Adenocarcinoma
16%
Cellular Processes
16%
Stomach Carcinoma
16%
NS-398
16%
Immunology and Microbiology
Promoter Region
100%
Fibrinogen
66%
Colony Forming Unit S
33%
Survival Rate
33%
Cancer Tissue
33%
Colony-Forming Unit
33%
Notch
33%
Stomach
33%
Prostaglandin E2
33%
Biochemistry, Genetics and Molecular Biology
Cyclooxygenase
100%
Intracellular Receptor
66%
Promoter Region
50%
Fibrinogen
33%
Tumor Progression
16%
Survival Rate
16%
Colony Forming Unit S
16%
Notch
16%
COX-2 Inhibitor
16%
Prostaglandin E2
16%
NS-398
16%